()
 

Overview

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

597 Laurier Boulevard
Mont-Saint-Hilaire, QC J3H6C4

tel:
fax:
http://www.axcan.com

,  



Investor Relations


Isabelle Adjahi
tel:
fax:
e-mail: axcan@axcan.com




Stock

Exchange: TSX
Industry: Industrial
Market Cap: $936.1M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.